Trial Profile
A Single Dose Phase I Clinical Study of Pazufloxacin Mesilate Ear Drops for the Patients With Otitis Media
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Oct 2017
Price :
$35
*
At a glance
- Drugs Pazufloxacin (Primary) ; Pazufloxacin (Primary)
- Indications Otitis media
- Focus Adverse reactions
- Sponsors Lee's Pharmaceutical
- 04 Nov 2015 New trial record